195 related articles for article (PubMed ID: 11070573)
1. Zolmitriptan provides effective migraine relief in adolescents.
Linder SL; Dowson AJ
Int J Clin Pract; 2000 Sep; 54(7):466-9. PubMed ID: 11070573
[TBL] [Abstract][Full Text] [Related]
2. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
Chen LC; Ashcroft DM
Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
[TBL] [Abstract][Full Text] [Related]
4. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
Gawel M; Aschoff J; May A; Charlesworth BR;
Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
[TBL] [Abstract][Full Text] [Related]
5. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G
Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
[TBL] [Abstract][Full Text] [Related]
7. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
[TBL] [Abstract][Full Text] [Related]
8. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
[TBL] [Abstract][Full Text] [Related]
9. Almotriptan and zolmitriptan in the acute treatment of migraine.
Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
[TBL] [Abstract][Full Text] [Related]
10. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen.
Evers S; Rahmann A; Kraemer C; Kurlemann G; Debus O; Husstedt IW; Frese A
Neurology; 2006 Aug; 67(3):497-9. PubMed ID: 16775229
[TBL] [Abstract][Full Text] [Related]
11. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
[TBL] [Abstract][Full Text] [Related]
12. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
[TBL] [Abstract][Full Text] [Related]
13. Zolmitriptan provides consistent migraine relief when used in the long-term.
Tuchman M; Edvinsson L; Geraud G; Korczyn A; Mauskop A; Pfaffenrath V
Curr Med Res Opin; 1999; 15(4):272-81. PubMed ID: 10640259
[TBL] [Abstract][Full Text] [Related]
14. [Zolmitriptan in treatment of migraine attack--the ARES Study].
Sturzenegger M; Daems K; Billeter M
Schweiz Med Wochenschr; 2000 Dec; 130(51-52):1984-93. PubMed ID: 11688066
[TBL] [Abstract][Full Text] [Related]
15. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
16. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
Tuchman M; Hee A; Emeribe U; Silberstein S
CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
[TBL] [Abstract][Full Text] [Related]
19. Patient preference for triptan formulations: a prospective study with zolmitriptan.
Dowson A; Bundy M; Salt R; Kilminster S
Headache; 2007 Sep; 47(8):1144-51. PubMed ID: 17883519
[TBL] [Abstract][Full Text] [Related]
20. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
